Lenalidomide in combination with rituximab, dexamethasone, high-dose ARA-C and cisplatinum as salvage therapy in refractory or relapsed aggressive B-cell non-hodgkin-lymphoma - an open-label, multicentre phase I/II study (DSHNHL-R6)

Related articles

1. Daratumumab or Elotuzumab Plus Lenalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma: An Indirect Comparison Based on Reconstructing Individual Patient Data from Kaplan-Meier Overall Survival Curves Using an Artificial-Intelligence Algorithm

   This article has 1 author:

   1. Andrea Messori

2. Randomized phase 3 study of intermittent or continuous Panitumumab plus FOLFIRI for first-line treatment of patients with unresectable left-sided RAS/BRAF wild-type metastatic colorectal cancer: the IMPROVE-2 trial

   This article has 57 authors:

   1. Antonio Avallone
   2. Alfonso De Stefano
   3. Michele Orditura
   4. Emiliano Tamburini
   5. Giuseppe Santabarbara
   6. Alfredo Colombo
   7. Maria Maddalena Laterza
   8. Teresa Troiani
   9. Francesca Bergamo
   10. Vincenzo Montesarchio
   11. Claudio Lotesoriere
   12. Tiziana Pia Latiano
   13. Alberto Zaniboni
   14. Matteo Landriscina
   15. Filippo Pietrantonio
   16. Salvatore Pisconti
   17. Rossana Berardi
   18. Domenico Bilancia
   19. Silvana Leo
   20. Alessandro Pastorino
   21. Federica Tosi
   22. Lorenzo Antonuzzo
   23. Carlo Garufi
   24. Francesco Giuliani
   25. Luigi Pio Guerrera
   26. Maria Giulia Zampino
   27. Raffaele Addeo
   28. Livio Blasi
   29. Katia Cannita
   30. Marta Caporale
   31. Alessio Cogoni
   32. Chiara Cremolini
   33. Bruno Daniele
   34. Emanuela Dell’Aquila
   35. Massimo Di Maio
   36. Davide Pastorelli
   37. Michele Pavarana
   38. Ferdinando Riccardi
   39. Giampaolo Tortora
   40. Stefano Cordio
   41. Pierosandro Tagliaferri
   42. Claudia Castiglioni
   43. Antonella Argentiero
   44. Laura Forti
   45. Maria Banzi
   46. Marco Tampellini
   47. Salvatore Corallo
   48. Stefania Mosconi
   49. Martina Torchio
   50. Umberto Malapelle
   51. Giancarlo Troncone
   52. Antonella De Luca
   53. Nicola Normanno
   54. Elena Di Gennaro
   55. Diana Giannarelli
   56. Alfredo Budillon
   57. Roberto Bordonaro

3. Platinum Selection in Immune Checkpoint Inhibitor-Based Therapy for Recurrent or Metastatic Head and Neck Cancer: A Multi-Institutional Retrospective Study

   This article has 8 authors:

   1. JUMPEI YOSHIDA
   2. NAOKI FUKUDA
   3. TAKUMI ITO
   4. KENJI NAKANO
   5. CHIYOE KITAGAWA
   6. HIROKI MITANI
   7. SHUNJI TAKAHASHI
   8. YUJI MIURA